• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mymd Pharmaceuticals Inc (NQ: MYMD )

    1.820 UNCHANGED
    Last Price Updated: 3:38 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Mymd Pharmaceuticals Inc

    < Previous 1 2 3 4 5 6 Next >
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
    Shares of LumiraDx Limited (NASDAQ: LMDX) fell sharply in pre-market trading after the company agreed to sell its point-of-care technology platform to Roche. LumiraDx shares dipped 19.7% to $0.0517 in... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. 
    Via Benzinga
    MyMD Pharmaceuticals Releases Positive Clinical Trial Results For Sarcopenia Treatment Drug
    A condition that commonly affects elderly populations, sarcopenia results in the gradual loss of strength and physical function and has become an important healthcare issue worldwide in recent years. A... 
    Via Benzinga
    Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
    Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter results. Bridgeline Digital posted a narrower-than-expected loss for its fourth... 
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
    Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape... 
    Via Benzinga
    Exposures Product Safety
    MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Five Hours Of Pain Relief? Preclinical Study Shows Promising Results With This Non-Toxic CBD
    MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) announced on Thursday the results from a preclinical study of its investigational cannabinoid Supera-CBD, a novel, synthetic, non-toxic cannabidiol (CBD)... 
    Via Benzinga
    MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    More Personal Portfolio: Biotech, Commodities, And Gold
    In a few years we will know if that was an extraordinarily opportunistic moment, or a long and frustrating rabbit hole. 
    Via Talk Markets
    MyMD Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
    The Dow Jones closed lower by over 1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    FDA Accepts MyMD Pharmaceuticals’ Investigational New Drug Application (IND) for Phase 2 Study of oral TNF-α inhibitor MYMD-1® in Rheumatoid Arthritis (RA)
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    It's time to start off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning! 
    Via InvestorPlace
    MyMD Pharmaceuticals to Hold Conference Call Today to Discuss Phase 2 Trial Results
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    It's time for a look at the biggest pre-market stock movers as we check out the latest news worth reading on Tuesday morning! 
    Via InvestorPlace
    Why Is MyMD Pharmaceuticals Stock Gaining Today?
    MyMD Pharmaceuticals Inc (NASDAQ: MYMD) announced topline results from its randomized Phase 2 study of oral TNF-α inhibitor, MYMD-1, in patients with chronic inflammation associated with 
    Via Benzinga
    MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Generation Oral TNF-α Inhibitor MYMD-1® in Sarcopenia/Age-Related Frailty
    From MyMD Pharmaceuticals, Inc.
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session
    Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer. 
    Via Benzinga
    Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.